About Health Insurance Innovations (NASDAQ:HIIQ)
Health Insurance Innovations, Inc. operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers short-term medical plans that provides three months of health insurance coverage with various deductible and copay levels; health benefit insurance plans, which offer daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits; and supplemental insurance products, including pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies. The company designs and structures individual and family health insurance plans, and supplemental products in concert with insurance carriers and discount benefit providers; and market them to individuals through a network of distributors. Health Insurance Innovations, Inc. was founded in 2008 and is based in Tampa, Florida.
Industry, Sector and Symbol
Industry Insurance agents, brokers, & service
Sub-IndustryLife & Health Insurance
SectorFinance
SymbolNASDAQ:HIIQ
CUSIP42225K10
Phone813-397-1187
Debt
Debt-to-Equity RatioN/A
Current Ratio1.46%
Quick Ratio1.46%
Price-To-Earnings
Trailing P/E Ratio23.75
Forward P/E Ratio14.62
P/E GrowthN/A
Sales & Book Value
Annual Sales$250.48 million
Price / Sales1.89
Cash Flow$1.4608 per share
Price / Cash19.51
Book Value$6.61 per share
Price / Book4.31
Profitability
EPS (Most Recent Fiscal Year)$1.20
Net Income$17.88 million
Net Margins7.14%
Return on Equity21.27%
Return on Assets13.30%
Miscellaneous
Employees199
Outstanding Shares16,570,000
Health Insurance Innovations (NASDAQ:HIIQ) Frequently Asked Questions
What is Health Insurance Innovations' stock symbol?
Health Insurance Innovations trades on the NASDAQ under the ticker symbol "HIIQ."
How will Health Insurance Innovations' stock buyback program work?
Health Insurance Innovations declared that its Board of Directors has approved a stock buyback program on Tuesday, October 17th 2017, which allows the company to repurchase $50,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are generally an indication that the company's leadership believes its stock is undervalued.
How were Health Insurance Innovations' earnings last quarter?
Health Insurance Innovations (NASDAQ:HIIQ) announced its earnings results on Wednesday, February, 28th. The financial services provider reported $0.37 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.34 by $0.03. The financial services provider had revenue of $69.50 million for the quarter, compared to analysts' expectations of $59.93 million. Health Insurance Innovations had a return on equity of 21.27% and a net margin of 7.14%. The firm's revenue was up 35.2% compared to the same quarter last year. View Health Insurance Innovations' Earnings History.
What guidance has Health Insurance Innovations issued on next quarter's earnings?
Health Insurance Innovations issued an update on its FY18 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of $2.45-$2.55 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.95. The company issued revenue guidance of $290-$300 million, compared to the consensus revenue estimate of $273.16 million.
What price target have analysts set for HIIQ?
8 brokerages have issued twelve-month price objectives for Health Insurance Innovations' stock. Their forecasts range from $34.60 to $60.00. On average, they anticipate Health Insurance Innovations' share price to reach $44.70 in the next twelve months. View Analyst Ratings for Health Insurance Innovations.
What are Wall Street analysts saying about Health Insurance Innovations stock?
Here are some recent quotes from research analysts about Health Insurance Innovations stock:
- 1. Cantor Fitzgerald analysts commented, "Solid 4Q17 performance. Revenue of $69.5 million (+35.1% y/y) was above FactSet consensus of $59.9 million and our estimate of $61.2 million. Revenue growth was driven primarily by a rise in policies in force during the open enrollment period for ACA plans. Adjusted EBITDA was $10.5 million vs. $8.9 million in 4Q16. Adjusted EPS were $0.37 vs. FactSet consensus of $0.34 and our estimate of $0.37. HIIQ continues to generate strong free cash flow. Free cash flow was $39.5 million and $15.1 million in 2017 and 2016, respectively." (3/1/2018)
- 2. According to Zacks Investment Research, "Health Insurance Innovations, Inc. operates as a developer and administrator of web-based individual health insurance plans and ancillary products. Its product portfolio consists of short-term medical plans, accident, sickness & hospital medical plans, ancillary insurance, life insurance, lifestyle and discount services. Health Insurance Innovations, Inc. is based in Tampa, Florida. " (2/14/2018)
- 3. Canaccord Genuity analysts commented, "We reiterate our BUY rating and $39 PT. Issued today, (preliminary) final ACA enrollment figures at 8.8M fell ~400K short of last year, which is more than some experts expected given the headwinds the enrollment process faced this year. However, we maintain our view that it is difficult to gauge how the ACA enrollment levels (vs. last year) will impact HIIQ. On another note, the tax bill will repeal the individual mandate in 2019, which we explain below should be positive for demand for HIIQ’s offering. We remain bullish on HIIQ and believe that the longer-term outlook remains favorable." (12/22/2017)
Who are some of Health Insurance Innovations' key competitors?
Who are Health Insurance Innovations' key executives?
Health Insurance Innovations' management team includes the folowing people:
- Mr. Gavin D. Southwell, Pres & CEO (Age 39)
- Mr. Michael W. Kosloske, Founder, Chief of Product Innovation & Director (Age 54)
- Sheldon X. Wang, Chief Technology Officer (Age 59)
- Mr. Bruce A. Telkamp, Director (Age 51)
- Mr. Michael D. Hershberger, Chief Financial Officer, Treasurer and Sec. (Age 55)
Has Health Insurance Innovations been receiving favorable news coverage?
Media coverage about HIIQ stock has trended positive on Friday, Accern Sentiment reports. Accern identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Health Insurance Innovations earned a coverage optimism score of 0.26 on Accern's scale. They also assigned media coverage about the financial services provider an impact score of 46.62 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.
How do I buy shares of Health Insurance Innovations?
Shares of HIIQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Health Insurance Innovations' stock price today?
One share of HIIQ stock can currently be purchased for approximately $28.50.
How big of a company is Health Insurance Innovations?
Health Insurance Innovations has a market capitalization of $469.82 million and generates $250.48 million in revenue each year. The financial services provider earns $17.88 million in net income (profit) each year or $1.20 on an earnings per share basis. Health Insurance Innovations employs 199 workers across the globe.
How can I contact Health Insurance Innovations?
Health Insurance Innovations' mailing address is 15438 N. FLORIDA AVENUE SUITE 201, TAMPA FL, 33613. The financial services provider can be reached via phone at 813-397-1187 or via email at [email protected]
MarketBeat Community Rating for Health Insurance Innovations (HIIQ)
MarketBeat's community ratings are surveys of what our community members think about Health Insurance Innovations and other stocks. Vote "Outperform" if you believe HIIQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HIIQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
Health Insurance Innovations (NASDAQ:HIIQ) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for Health Insurance Innovations in the last 12 months. Their average twelve-month price target is $44.70, suggesting that the stock has a possible upside of 56.84%. The high price target for HIIQ is $60.00 and the low price target for HIIQ is $34.60. There are currently 8 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 3.00 | 3.00 | 2.86 | 2.88 |
| Ratings Breakdown: | 0 Sell Rating(s)
0 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
0 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $44.70 | $44.70 | $34.40 | $32.00 |
| Price Target Upside: | 56.84% upside | 37.33% upside | 38.15% upside | 51.84% upside |
Health Insurance Innovations (NASDAQ:HIIQ) Consensus Price Target History
Health Insurance Innovations (NASDAQ:HIIQ) Analyst Ratings History
Show:
(Data available from 4/27/2016 forward)
Health Insurance Innovations (NASDAQ:HIIQ) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Health Insurance Innovations (NASDAQ HIIQ) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 30.00%
Institutional Ownership Percentage: 79.36%
Health Insurance Innovations (NASDAQ HIIQ) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/11/2018 | Anthony Barkett | Director | Buy | 5,512 | $6.40 | $35,276.80 | 6,512 |  |
| 9/15/2018 | Anthony Barkett | Director | Buy | 13,574 | $22.00 | $298,628.00 | 6,512 | |
| 2/28/2018 | Sheldon Wang | CTO | Sell | 5,000 | $31.80 | $159,000.00 | 74,001 | |
| 2/16/2018 | Sheldon Wang | Insider | Sell | 30,000 | $30.49 | $914,700.00 | 94,001 | |
| 1/25/2018 | Sheldon Wang | CTO | Sell | 5,000 | $28.30 | $141,500.00 | 109,001 | |
| 1/4/2018 | Sheldon Wang | CTO | Sell | 5,000 | $25.00 | $125,000.00 | 122,769 | |
| 1/2/2018 | Sheldon Wang | Insider | Sell | 11,232 | $25.00 | $280,800.00 | 137,769 | |
| 12/28/2017 | Sheldon Wang | CTO | Sell | 1,232 | $25.00 | $30,800.00 | 137,769 | |
| 12/27/2017 | Sheldon Wang | Insider | Sell | 10,000 | $25.00 | $250,000.00 | 144,001 | |
| 12/21/2017 | Sheldon Wang | Insider | Sell | 10,000 | $25.20 | $252,000.00 | 159,001 | |
| 12/19/2017 | Sheldon Wang | Insider | Sell | 10,000 | $26.30 | $263,000.00 | 169,001 | |
| 12/15/2017 | Sheldon Wang | CTO | Sell | 5,000 | $27.40 | $137,000.00 | 194,001 | |
| 12/13/2017 | Sheldon Wang | CTO | Sell | 5,000 | $25.00 | $125,000.00 | 194,001 | |
| 12/8/2017 | Robert S Murley | Director | Buy | 5,000 | $22.50 | $112,500.00 | 39,734 | |
| 9/7/2017 | Sheldon Wang | Insider | Sell | 4,530 | $32.73 | $148,266.90 | 224,894 | |
| 9/6/2017 | Sheldon Wang | Insider | Sell | 16,307 | $31.69 | $516,768.83 | 229,001 | |
| 9/1/2017 | Bruce Telkamp | CEO of HealthPocket | Sell | 9,970 | $36.19 | $360,814.30 | 19,500 | |
| 9/1/2017 | Michael D Hershberger | CFO | Sell | 17,769 | $31.42 | $558,301.98 | 94,569 | |
| 9/1/2017 | Robert S Murley | Director | Buy | 3,000 | $30.21 | $90,630.00 | 34,734 | |
| 8/7/2017 | Bruce Telkamp | CEO of HealthPocket | Sell | 11,501 | $31.45 | $361,706.45 | 17,500 | |
| 8/2/2017 | Bruce Telkamp | CEO | Sell | 15,000 | $26.27 | $394,050.00 | 29,201 | |
| 8/1/2017 | Michael D Hershberger | CFO | Sell | 5,000 | $27.49 | $137,450.00 | 98,569 | |
| 7/31/2017 | Bruce Telkamp | CEO | Sell | 15,000 | $27.76 | $416,400.00 | 45,801 | |
| 7/26/2017 | Bruce Telkamp | CEO | Sell | 30,000 | $28.30 | $849,000.00 | 74,001 | |
| 7/24/2017 | Bruce Telkamp | CEO | Sell | 15,000 | $27.76 | $416,400.00 | 74,001 | |
| 7/18/2017 | Bruce Telkamp | CEO | Sell | 30,000 | $26.68 | $800,400.00 | 104,001 | |
| 7/17/2017 | Bruce Telkamp | CEO | Sell | 15,000 | $26.50 | $397,500.00 | 104,001 | |
| 7/13/2017 | Sheldon Wang | Insider | Sell | 4,750 | $25.80 | $122,550.00 | 224,001 | |
| 7/3/2017 | Michael D Hershberger | CFO | Sell | 5,000 | $23.22 | $116,100.00 | 105,369 | |
| 6/19/2017 | Sheldon Wang | Insider | Sell | 26,421 | $22.99 | $607,418.79 | 262,577 | |
| 6/14/2017 | Sheldon Wang | CTO | Sell | 16,421 | $21.79 | $357,813.59 | 262,577 | |
| 6/12/2017 | Sheldon Wang | Insider | Sell | 5,149 | $21.60 | $111,218.40 | 228,751 | |
| 5/26/2017 | Bruce Telkamp | CEO | Sell | 3,901 | $22.60 | $88,162.60 | 107,071 | |
| 5/12/2017 | Bruce Telkamp | CEO | Sell | 18,745 | $21.94 | $411,265.30 | 107,211 | |
| 5/12/2017 | Sheldon Wang | Insider | Sell | 12,417 | $21.18 | $262,992.06 | 226,251 | |
| 5/10/2017 | Bruce Telkamp | CEO | Sell | 24,179 | $20.25 | $489,624.75 | 116,501 | |
| 5/9/2017 | Michael D Hershberger | CFO | Sell | 15,000 | $20.37 | $305,550.00 | 93,369 | |
| 5/5/2017 | Sheldon Wang | Insider | Sell | 24,750 | $19.73 | $488,317.50 | 236,001 | |
| 4/24/2017 | Bruce Telkamp | CEO | Sell | 4,750 | $15.80 | $75,050.00 | 101,501 | |
| 4/19/2017 | Bruce Telkamp | CEO of HealthPocket and Consumer Division | Sell | 14,750 | $15.21 | $224,347.50 | 111,251 | |
| 4/17/2017 | Bruce Telkamp | CEO of HealthPocket and Consumer Division | Sell | 9,750 | $15.10 | $147,225.00 | 111,251 | |
| 4/12/2017 | Bruce Telkamp | HealthPocket and Consumer Division CEO | Sell | 10,000 | $16.37 | $163,700.00 | 126,001 | |
| 4/3/2017 | Michael D Hershberger | CFO | Sell | 5,000 | $15.94 | $79,700.00 | 113,369 | |
| 3/15/2017 | Sheldon Wang | Insider | Sell | 7,560 | $16.77 | $126,781.20 | 250,001 | |
| 3/13/2017 | Michael W Kosloske | Insider | Sell | 3,000,000 | $13.16 | $39,480,000.00 | 100 | |
| 3/9/2017 | Robert S Murley | Director | Sell | 10,000 | $16.04 | $160,400.00 | 14,700 | |
| 3/1/2017 | Michael D Hershberger | CFO | Sell | 5,000 | $17.90 | $89,500.00 | 118,369 | |
| 1/20/2017 | Cannell Capital Llc | Major Shareholder | Sell | 367,452 | $19.99 | $7,345,365.48 | | |
| 12/8/2016 | Sheldon Wang | Insider | Sell | 15,000 | $14.07 | $211,050.00 | 265,001 | |
| 11/21/2016 | Bruce Telkamp | CEO | Sell | 59,000 | $10.15 | $598,850.00 | 183,281 | |
| 11/21/2016 | Michael D Hershberger | CFO | Sell | 39,500 | $10.18 | $402,110.00 | 160,369 | |
| 10/28/2016 | Cannell Capital Llc | Major Shareholder | Buy | 150 | $4.75 | $712.50 | | |
| 8/11/2016 | Josef A Denother | COO | Buy | 1,000 | $4.60 | $4,600.00 | 1,000 | |
| 8/10/2016 | Michael D Hershberger | CFO | Buy | 1,000 | $4.49 | $4,490.00 | 166,140 | |
| 8/10/2016 | Patrick Mcnamee | CEO | Buy | 15,000 | $4.52 | $67,800.00 | | |
| 7/18/2016 | Cannell Capital Llc | Major Shareholder | Buy | 4,343 | $3.93 | $17,067.99 | | |
| 6/30/2016 | Cannell Capital Llc | Major Shareholder | Buy | 2,913 | $3.94 | $11,477.22 | | |
| 6/29/2016 | Cannell Capital Llc | Major Shareholder | Buy | 11,144 | $3.94 | $43,907.36 | | |
| 6/28/2016 | Cannell Capital Llc | Major Shareholder | Buy | 200 | $3.95 | $790.00 | | |
| 6/27/2016 | Cannell Capital Llc | Major Shareholder | Buy | 6,167 | $3.95 | $24,359.65 | | |
| 6/17/2016 | Cannell Capital Llc | Major Shareholder | Buy | 1,600 | $4.00 | $6,400.00 | | |
| 6/16/2016 | Cannell Capital Llc | Major Shareholder | Buy | 45,000 | $4.01 | $180,450.00 | | |
| 5/18/2016 | Cannell Capital Llc | Major Shareholder | Buy | 600 | $6.21 | $3,726.00 | | |
| 5/6/2016 | Cannell Capital Llc | Major Shareholder | Buy | 8,399 | $6.22 | $52,241.78 | | |
| 5/2/2016 | Cannell Capital Llc | Major Shareholder | Buy | 4,644 | $6.14 | $28,514.16 | | |
| 4/21/2016 | Cannell Capital Llc | Major Shareholder | Buy | 3,390 | $6.16 | $20,882.40 | | |
| 4/19/2016 | Cannell Capital Llc | Major Shareholder | Buy | 3,898 | $6.17 | $24,050.66 | | |
| 4/12/2016 | Cannell Capital Llc | Major Shareholder | Buy | 3,810 | $5.74 | $21,869.40 | | |
| 4/6/2016 | Cannell Capital Llc | Major Shareholder | Buy | 11,190 | $6.00 | $67,140.00 | | |
| 4/1/2016 | Cannell Capital Llc | Major Shareholder | Buy | 27,213 | $6.21 | $168,992.73 | | |
| 3/29/2016 | Cannell Capital Llc | Major Shareholder | Buy | 6,175 | $6.10 | $37,667.50 | | |
| 3/22/2016 | Cannell Capital Llc | Major Shareholder | Buy | 398 | $6.07 | $2,415.86 | | |
| 3/17/2016 | Cannell Capital Llc | Major Shareholder | Buy | 3,949 | $6.05 | $23,891.45 | | |
| 3/10/2016 | Cannell Capital Llc | Major Shareholder | Buy | 7,500 | $6.14 | $46,050.00 | | |
| 3/8/2016 | Cannell Capital Llc | Major Shareholder | Buy | 31,514 | $6.12 | $192,865.68 | | |
| 11/19/2015 | Cannell Capital Llc | Major Shareholder | Buy | 59,248 | $4.55 | $269,578.40 | | |
| 11/16/2015 | Cannell Capital Llc | Major Shareholder | Buy | 38,599 | $4.59 | $177,169.41 | | |
| 8/17/2015 | Michael W Kosloske | CEO | Buy | 26,079 | $4.76 | $124,136.04 | | |
| 7/7/2015 | Cannell Capital Llc | Major Shareholder | Buy | 11,488 | $4.77 | $54,797.76 | | |
| 7/6/2015 | Cannell Capital Llc | Major Shareholder | Buy | 45,572 | $4.97 | $226,492.84 | | |
| 6/30/2015 | Cannell Capital Llc | Major Shareholder | Buy | 9,679 | $4.92 | $47,620.68 | | |
| 6/29/2015 | Cannell Capital Llc | Major Shareholder | Buy | 9,477 | $4.92 | $46,626.84 | | |
| 6/12/2015 | Paul G Gabos | Director | Buy | 10,000 | $4.95 | $49,500.00 | | |
| 8/18/2014 | Paul G Gabos | Director | Buy | 10,000 | $12.10 | $121,000.00 | | |
| 7/2/2014 | Michael W Kosloske | CEO | Sell | 14,475 | $11.93 | $172,686.75 | | |
| 6/17/2014 | Michael W Kosloske | CEO | Sell | 16,197 | $10.38 | $168,124.86 | | |
| 6/5/2014 | Michael W Kosloske | CEO | Sell | 5,943 | $10.21 | $60,678.03 | | |
| 5/22/2014 | Michael Kosloske | CEO | Sell | 4,700 | $10.39 | $48,833.00 | 36,715 | |
| 5/20/2014 | Michael Kosloske | CEO | Sell | 2,010 | $10.37 | $20,843.70 | 41,415 | |
| 4/3/2014 | Michael Kosloske | CEO | Sell | 14,475 | $10.16 | $147,066.00 | 43,425 | |
| 3/21/2014 | Paul Gabos | Director | Buy | 5,000 | $11.80 | $59,000.00 | 5,000 | |
| 3/6/2014 | Michael Kosloske | CEO | Sell | 14,475 | $12.18 | $176,305.50 | 57,900 | |
| 2/6/2014 | Michael Kosloske | CEO | Sell | 14,480 | $11.18 | $161,886.40 | 72,375 | |
| 12/13/2013 | Michael Kosloske | CEO | Sell | 10,000 | $10.19 | $101,900.00 | 86,855 | |
| 10/15/2013 | Michael D Hershberger | CFO | Sell | 1,500 | $13.53 | $20,295.00 | | |
(Data available from 1/1/2013 forward)
Health Insurance Innovations (NASDAQ HIIQ) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | CEO of one of Tampa Bay's smallest public companies gets one of the area's biggest pay packages
www.bizjournals.com - April 26 at 4:00 PM |
 | Scott+Scott Attorneys at Law LLP is Investigating Derivative Claims on Behalf of Shareholders of Health Insurance ...
www.businesswire.com - April 26 at 4:00 PM |
 | Health Insurance Innovations, Inc. to Announce First Quarter 2018 Financial and Operating Results on Wednesday ...
www.nasdaq.com - April 26 at 4:00 PM |
 | Health Insurance Innovations, Inc. to Announce First Quarter 2018 Financial and Operating Results on Wednesday, May 2, 2018
feeds.benzinga.com - April 24 at 5:01 PM |
 | Health Insurance Innovations (HIIQ) Director Purchases $35,276.80 in Stock
www.americanbankingnews.com - April 24 at 10:14 AM |
| Health Insurance Innovations (HIIQ) Director Anthony Barkett Purchases 13,574 Shares
www.americanbankingnews.com - April 24 at 10:14 AM |
 | Zacks Industry Outlook Highlights: FGL Holdings, Health Insurance Innovations and China Life Insurance
finance.yahoo.com - April 19 at 10:09 AM |
| Zacks Investment Research Lowers Health Insurance Innovations (HIIQ) to Hold
www.americanbankingnews.com - April 18 at 11:54 PM |
 | Rate Environment, Higher Employment to Aid Life Insurers
www.zacks.com - April 18 at 4:06 PM |
 | Bare-Bones Health Policies Are Cheaper Than ACA Plans—and Riskier Too
www.wsj.com - April 18 at 10:08 AM |
| Health Insurance Innovations (HIIQ) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - April 15 at 8:19 AM |
| Craig Hallum Reiterates Buy Rating for Health Insurance Innovations (HIIQ)
www.americanbankingnews.com - April 13 at 6:39 PM |
| Zacks: Brokerages Expect Health Insurance Innovations (HIIQ) Will Post Quarterly Sales of $64.36 Million
www.americanbankingnews.com - April 12 at 3:05 AM |
 | Health Insurance Innovations up 6%
seekingalpha.com - April 11 at 4:06 PM |
| ValuEngine Lowers Health Insurance Innovations (HIIQ) to Hold
www.americanbankingnews.com - April 10 at 4:29 PM |
| Brokerages Anticipate Health Insurance Innovations (HIIQ) Will Post Earnings of $0.51 Per Share
www.americanbankingnews.com - April 10 at 11:13 AM |
| Health Insurance Innovations' (HIIQ) Overweight Rating Reiterated at Cantor Fitzgerald
www.americanbankingnews.com - April 8 at 11:55 PM |
| Health Insurance Innovations (HIIQ) Upgraded at ValuEngine
www.americanbankingnews.com - April 8 at 12:22 PM |
| Health Insurance Innovations (HIIQ) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 7 at 2:46 PM |
| Northland Securities Reiterates Buy Rating for Health Insurance Innovations (HIIQ)
www.americanbankingnews.com - April 7 at 11:38 AM |
| Health Insurance Innovations (HIIQ) Downgraded to Hold at ValuEngine
www.americanbankingnews.com - April 3 at 1:55 PM |
| Health Insurance Innovations (HIIQ) CEO Sells $360,814.30 in Stock
www.americanbankingnews.com - April 2 at 10:20 PM |
| Health Insurance (HIIQ) Soars Past 80% in a Year: Here's Why
finance.yahoo.com - April 2 at 4:06 PM |
| Health Insurance (HIIQ) Soars Past 80% in a Year: Here's Why
www.zacks.com - April 2 at 10:35 AM |
| Health Insurance Innovations (HIIQ) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - March 31 at 12:42 PM |
| How Health Insurance Innovations (HIIQ) Stock Stands Out in a Strong Industry
finance.yahoo.com - March 28 at 10:02 AM |
| Health Insurance Innovations (HIIQ) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - March 27 at 11:01 PM |
| Health Insurance Innovations (HIIQ) Upgraded to "Buy" by BidaskClub
www.americanbankingnews.com - March 26 at 11:30 PM |
| $64.36 Million in Sales Expected for Health Insurance Innovations (HIIQ) This Quarter
www.americanbankingnews.com - March 26 at 7:02 AM |
| Health Insurance Innovations (HIIQ) Upgraded to "Buy" at ValuEngine
www.americanbankingnews.com - March 25 at 5:23 PM |
| BidaskClub Upgrades Health Insurance Innovations (HIIQ) to "Buy"
www.americanbankingnews.com - March 24 at 8:54 PM |
| Health Insurance Innovations (HIIQ) Upgraded by UBS to "Outperform"
www.americanbankingnews.com - March 24 at 2:13 PM |
| $0.51 EPS Expected for Health Insurance Innovations (HIIQ) This Quarter
www.americanbankingnews.com - March 24 at 11:28 AM |
| Health Insurance Innovations (HIIQ) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - March 21 at 11:40 AM |
| The Zacks Analyst Blog Highlights: BancFirst, Health Insurance, EOG, Wynn and American Airlines
finance.yahoo.com - March 21 at 10:51 AM |
| Spring Has Come to Warm Us All: 5 Top Stocks to Blossom - Nasdaq
www.nasdaq.com - March 20 at 4:11 PM |
| 5 Stocks to Make the Most of an Imminent Rate Hike - Nasdaq
www.nasdaq.com - March 20 at 4:11 PM |
 | Health Insurance Innovations, Inc. To Participate at the William Blair Insure Tech Conference on March 21, 2018 - GlobeNewswire (press release)
globenewswire.com - March 16 at 4:12 PM |
| Public Awareness Of Short-Term Health Increases Dramatically
www.bizjournals.com - March 14 at 4:07 PM |
 | Scott+Scott Attorneys at Law LLP is Investigating Derivative Claims on Behalf of Shareholders of Health Insurance ... - PR Newswire (press release)
www.prnewswire.com - March 14 at 12:44 PM |
| 6 Reasons Why You Should Hold Torchmark in Your Portfolio - Nasdaq
www.nasdaq.com - March 14 at 12:44 PM |
| Scott+Scott Attorneys at Law LLP is Investigating Derivative Claims on Behalf of Shareholders of Health Insurance Innovations, Inc. (HIIQ)
finance.yahoo.com - March 14 at 12:44 PM |
| Health Insurance Innovations, Inc. To Present at the 22nd Annual CFANY Insurance Industry Conference on March 19 ... - GlobeNewswire (press release)
globenewswire.com - March 10 at 4:13 PM |
| Health Insurance Innovations, Inc. To Present at the 22nd Annual CFANY Insurance Industry Conference on March 19, 2018
feeds.benzinga.com - March 9 at 2:43 PM |
| $64.36 Million in Sales Expected for Health Insurance Innovations Inc (HIIQ) This Quarter
www.americanbankingnews.com - March 9 at 7:11 AM |
| Health Insurance Innovations, Inc. To Present at the 30th Annual Roth Capital Growth Stock Conference on March 13 ... - GlobeNewswire (press release)
globenewswire.com - March 8 at 11:18 AM |
| Health Insurance Innovations, Inc. To Present at the 30th Annual Roth Capital Growth Stock Conference on March 13, 2018
finance.yahoo.com - March 7 at 4:03 PM |
| Canaccord Genuity Reiterates Buy Rating for Health Insurance Innovations (HIIQ)
www.americanbankingnews.com - March 3 at 6:04 PM |
| Health Insurance Innovations' (HIIQ) CEO Gavin Southwell on Q4 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 3 at 3:58 PM |
| Sheldon Wang Sells 5,000 Shares of Health Insurance Innovations Inc (HIIQ) Stock
www.americanbankingnews.com - March 2 at 6:56 PM |
Health Insurance Innovations (NASDAQ:HIIQ) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Health Insurance Innovations (NASDAQ:HIIQ) Income Statement, Balance Sheet and Cash Flow Statement
Health Insurance Innovations (NASDAQ HIIQ) Stock Chart for Friday, April, 27, 2018
Loading chart…
